Companies

Silexion Therapeutics Corp

SLXN, SLXNW · CIK 0002022416 · operating

$0.03-1.16%Last updated Mar 2, 8:48 PM

Key Statistics

Valuation

Market Cap
P/E
Fwd P/E
PEG
P/S
P/B0.02
EV/EBITDA
EV/Rev

Profitability

Gross Margin
Op. Margin
Net Margin
ROE414.11%
ROA-576.98%
FCF Margin

Financial Health

Current Ratio0.64
Debt/Equity-1.72
Free Cash Flow-$8.42M
Div. Yield

Growth & Other

Revenue Growth
EPS Growth
Beta-0.04
52W High$0.034
52W Low$0.034

About Silexion Therapeutics Corp

Silexion Therapeutics Corp (SLXNW) is a biological products, (no diagnostic substances) company incorporated in Cayman Islands, listed on the Nasdaq. The stock currently trades at $0.03, down 1.16% today, with a 52-week range of $0.03–$0.04.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2024$26.36$26.36

Annual Reports (10-K) · 1 filings

Report DateFiledAccession Number
2024-12-312025-03-180001178913-25-000887SEC ↗